PL2523946T3 - Tricykliczne seskwiterpenowe laktony do stosowania w leczeniu otyłości i związanych chorób i stanów możliwych do leczenia nieterapeutycznego - Google Patents

Tricykliczne seskwiterpenowe laktony do stosowania w leczeniu otyłości i związanych chorób i stanów możliwych do leczenia nieterapeutycznego

Info

Publication number
PL2523946T3
PL2523946T3 PL11700612T PL11700612T PL2523946T3 PL 2523946 T3 PL2523946 T3 PL 2523946T3 PL 11700612 T PL11700612 T PL 11700612T PL 11700612 T PL11700612 T PL 11700612T PL 2523946 T3 PL2523946 T3 PL 2523946T3
Authority
PL
Poland
Prior art keywords
obesity
therapeutic
treatment
related diseases
sesquiterpene lactones
Prior art date
Application number
PL11700612T
Other languages
English (en)
Inventor
Torsten Grothe
Ernst Roemer
Philipp Wabnitz
Original Assignee
Neem Biotech Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neem Biotech Ltd. filed Critical Neem Biotech Ltd.
Publication of PL2523946T3 publication Critical patent/PL2523946T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL11700612T 2010-01-14 2011-01-13 Tricykliczne seskwiterpenowe laktony do stosowania w leczeniu otyłości i związanych chorób i stanów możliwych do leczenia nieterapeutycznego PL2523946T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10000282A EP2345646A1 (en) 2010-01-14 2010-01-14 Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
EP11700612.2A EP2523946B1 (en) 2010-01-14 2011-01-13 Tricyclic sesquiterpene lactones for used in the treatment of obesity and related diseases and non-therapeutic treatable conditions
PCT/EP2011/000110 WO2011085979A1 (en) 2010-01-14 2011-01-13 Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions

Publications (1)

Publication Number Publication Date
PL2523946T3 true PL2523946T3 (pl) 2018-02-28

Family

ID=42727406

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11700612T PL2523946T3 (pl) 2010-01-14 2011-01-13 Tricykliczne seskwiterpenowe laktony do stosowania w leczeniu otyłości i związanych chorób i stanów możliwych do leczenia nieterapeutycznego

Country Status (9)

Country Link
US (2) US20130023586A1 (pl)
EP (3) EP2345646A1 (pl)
DK (1) DK2523946T3 (pl)
ES (1) ES2652595T3 (pl)
HU (1) HUE037455T2 (pl)
NO (1) NO2523946T3 (pl)
PL (1) PL2523946T3 (pl)
PT (1) PT2523946T (pl)
WO (1) WO2011085979A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013103384A1 (en) 2012-01-06 2013-07-11 Elcelyx Therapeutics, Inc. Biguanide compositions and methods of treating metabolic disorders
HUE051738T2 (hu) 2011-01-07 2021-03-29 Anji Pharma Us Llc Kemoszenzoros receptorligandum-alapú terápiák
US9795792B2 (en) 2011-02-25 2017-10-24 Medtronic, Inc. Emergency mode switching for non-pacing modes
ITMI20111670A1 (it) * 2011-09-16 2013-03-17 Indena Spa Estratti di cynara scolimus per il trattamento di dislipidemie
BR112014016810A8 (pt) 2012-01-06 2017-07-04 Elcelyx Therapeutics Inc composições e métodos para tratamento de distúrbios metabólicos
JP6026639B2 (ja) * 2012-04-02 2016-11-16 ソンギュン バイオテック カンパニー リミテッドＳｕｎｇ Ｋｙｕｎ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． フジバカマ属の抽出物を含有する骨代謝疾患の予防及び治療用組成物及びその製造方法
WO2013171100A1 (en) 2012-05-16 2013-11-21 Joachim Hans Polyhydroxylated pentacyclic triterpene acids as hmg-coa reductase inhibitors
AR091739A1 (es) 2012-07-11 2015-02-25 Elcelyx Therapeutics Inc Composiciones y metodos para reducir el riesgo cardiometabolico
KR101378433B1 (ko) * 2012-11-05 2014-03-27 초당약품공업 주식회사 세스퀴터핀 락톤계 위장 질환 치료용 의약 조성물
KR101378431B1 (ko) * 2012-11-05 2014-03-27 초당약품공업 주식회사 세스퀴터핀 락톤계 위장 질환 치료용 의약 조성물
US20140193498A1 (en) 2013-01-05 2014-07-10 Elcelyx Therapeutics, Inc. Compositions and Methods for Treating Metabolic Disorders
CN104016952B (zh) * 2013-02-28 2016-05-18 东北林业大学 一种倍半萜活性成分及其制备方法与应用
FR3011180B1 (fr) * 2013-10-01 2017-01-06 Laboratoires De Biologie Vegetale Yves Rocher Utilisation d'un extrait d'artemisia montana dans une composition cosmetique amincissante
KR101926075B1 (ko) * 2017-01-05 2018-12-06 동신대학교산학협력단 명월초에서 분리한 화합물 등을 이용한 항당뇨 조성물
CN107118188A (zh) * 2017-05-09 2017-09-01 中国科学院新疆理化技术研究所 天山雪莲种子中的倍半萜内酯类化合物及其制备方法
CN108003174A (zh) * 2017-12-18 2018-05-08 南开大学 一种倍半萜衍生物的晶型及其制备方法与用途
KR102406792B1 (ko) * 2019-12-20 2022-06-10 주식회사 봄프렌즈 다이어트 기능성 개과 동물용 사료 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH617326A5 (pl) 1975-12-04 1980-05-30 Siegfried Ag
EP1175901B1 (en) * 1999-04-15 2006-05-31 Kaneka Corporation Peroxisome activator-responsive receptor agonists
US6530886B1 (en) 1999-10-08 2003-03-11 Tanita Corporation Method and apparatus for measuring subcutaneous fat using ultrasonic wave
ATE345126T1 (de) * 2001-08-15 2006-12-15 Meiji Dairies Corp Sesquiterpenoid-derivate mit adipozytendifferenzierungshemmender wirkung
KR100469612B1 (ko) * 2003-02-05 2005-02-02 주식회사 싸이제닉 흰씀바귀로부터 추출된 세스퀴테르펜 락톤계 화합물 및이를 함유하는 심혈관 질환 및 암 치료용 조성물
KR100552109B1 (ko) * 2003-02-05 2006-02-14 학교법인 경희대학교 흰씀바귀로부터 추출된 세스퀴테르펜 락톤 화합물을 함유하는 심혈관 질환 예방 및 치료용 조성물
KR100572621B1 (ko) 2003-03-19 2006-04-24 한국 한의학 연구원 비만 및 성인병 치료용 조성물
WO2004096252A1 (en) 2003-04-25 2004-11-11 Primavera Biosciences, Inc. Compositions and methods for weight loss
JP2006206532A (ja) 2005-01-31 2006-08-10 Ichimaru Pharcos Co Ltd ＮＦ−κＢ活性化抑制剤
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
ES2323815T3 (es) * 2007-03-07 2009-07-24 Indena S.P.A. Formulaciones que contienen extractos de cynara scolymus y de phaseolus vulgaris que son utiles para el tratamiento de la obesidad.
JP2008231031A (ja) * 2007-03-20 2008-10-02 Arkray Inc デヒドロエピアンドロステロン産生促進剤およびその用途
WO2009005115A1 (ja) * 2007-07-03 2009-01-08 Nisshin Pharma Inc. 脂肪細胞の小型化促進用組成物
KR100905419B1 (ko) * 2008-09-11 2009-07-02 연세대학교 산학협력단 세스퀴테르펜 유도체의 용도

Also Published As

Publication number Publication date
US20200055835A1 (en) 2020-02-20
WO2011085979A1 (en) 2011-07-21
ES2652595T3 (es) 2018-02-05
NO2523946T3 (pl) 2018-02-17
EP2523946A1 (en) 2012-11-21
EP3260449A1 (en) 2017-12-27
DK2523946T3 (en) 2018-01-08
EP2345646A1 (en) 2011-07-20
EP2523946B1 (en) 2017-09-20
PT2523946T (pt) 2017-12-13
US20130023586A1 (en) 2013-01-24
HUE037455T2 (hu) 2018-08-28
WO2011085979A4 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
HUE037455T2 (hu) Triciklusos szeszkviterpén laktonok elhízás és ezzel összefüggõ betegségek, továbbá nem-terápiásan kezelt állapotok kezelésére
EP2621501A4 (en) POLYCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS FOR THEIR USE IN THE TREATMENT OF VIRAL DISEASES
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
PL3208612T3 (pl) Kompozycje i sposoby leczenia chorób o podłożu immunologicznym
ZA201205683B (en) Probiotic composition for use in the treatment of bowel inflammation
IL225471A0 (en) Preparations and methods for the prevention and treatment of cancer
HK1166305A1 (zh) 用於治療炎症的組合物及方法
EP2558085A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER
IL225793A0 (en) Methods and preparations for curing insulin-related medical conditions
IL214349A0 (en) Compositions and methods for the treatment of cancer
EP2437780A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD FOR THE PREVENTION OF AUTOIMMUNE DISEASES
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases
HK1171677A1 (en) Composition for the treatment of hemorrhoids and related diseases
HK1211221A1 (en) Formulations for the treatment and prevention of obesity
EP2437738A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
EP2575824A4 (en) METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES
HRP20151393T8 (hr) UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE
EP2411031A4 (en) Methods and compositions for the treatment of cancer
EP2480099A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING METABOLIC DISEASES
EP2467492A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE AND PATHOGENIC DISEASES
PT2637974T (pt) Composição multifuncional para o tratamento de desinfecção da água e utilização desta composição
IL219050A0 (en) Pharmaceutical composition for the treatment of bladder disorders
ZA201005770B (en) The treatment of damaged skin
AU2010904906A0 (en) Methods and compositions for the treatment and prevention of skin disorders
HU0800083D0 (en) Pharmaceutical compositions for the treatment and prevention of tumorous diseases